Who is a candidate for high-dose interleukin-2 therapy for melanoma?

High-dose interleukin-2 (IL-2) therapy is Food and Drug Administration (FDA)-approved and considered standard treatment for patients with metastatic melanoma.

Skin cancer patients suitable for high-dose IL-2 therapy:

  • Must be diagnosed with metastatic melanoma (melanoma that has spread to other parts of the body)
  • Must be out of bed more than 50 percent of the day
  • Have relatively normal function of heart, lungs, kidneys, and liver
  • Have brain metastases treated and stable
  • Should not take/use steroids or steroid-containing compounds

Continue Learning about Melanoma Treatment

How is melanoma treated?
Honor Society of Nursing (STTI)Honor Society of Nursing (STTI)
Treatment options for melanoma depends on several factors, including the stage of the cancer and the...
More Answers
What are the follow up treatments for melanoma?
Dr. Ellen Marmur, MDDr. Ellen Marmur, MD
After the original surgical treatment, most patients will need to see their dermatologist for a skin...
More Answers
Will melanoma surgery leave a scar?
Jill Onesti, MDJill Onesti, MD
Melanoma surgery does leave a scar. Treatment of the original lesion on the skin consists of a "wide...
More Answers
How do different treatments for melanoma work?
Philip A. Friedlander, MDPhilip A. Friedlander, MD
Traditional chemotherapy attacks melanoma tumor cells in a non-specific way. In this video, Philip F...
More Answers

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.